Phase I Trials

Synexus in South Africa has a 36 bed Phase I unit located at its Pretoria site.  This unit, which has now been running for more than 5 years, has undertaken more than 25 Phase I/BE/BA and Phase IIa studies. 

These trials include:

  • Vaccines
  • Infectious diseases
  • HIV

For more information on Phase I trials please contact Synexus in South Africa:

Sanet Aspinall/Mark Shardelow:

By phone: +27 12 803 7733

By email:  sanet.aspinall@synexus-sa.co.za or mark.shardelow@addclinresearch.co.za

Click here to return to Phases and Study Types

 

Back to top ^

Feasibility

If you would like an assessment on a clinical trial please send us your details and we will get back to you.

Contact Us

Have more questions? Contact us for more information

Contact Us

Synexus Limited, Registered in England and Wales, Registered number 3724238, Registered Office: Sandringham House, Ackhurst Park, Chorley , Lancashire, PR7 1NY